Imaging modalities stand at the frontiers for progress in congestive heart failure (CHF)
screening, risk stratification and monitoring. Advancements in echocardiography (ECHO) and Magnetic
Resonance Imaging (MRI) have allowed for improved tissue characterizations, cardiac motion
analysis, and cardiac performance analysis under stress. Common cardiac comorbidities such as hypertension,
metabolic syndromes and chronic renal failure contribute to cardiac remodeling, sharing
similar pathophysiological mechanisms starting with interstitial changes, structural changes and finally
clinical CHF. These imaging techniques can potentially detect changes earlier. Such information
could have clinical benefits for screening, planning preventive therapies and risk stratifying patients.
Imaging reports have often focused on traditional measures without factoring these novel parameters.
This review is aimed at providing a synopsis on how we can use this information to assess
and monitor improvements for CHF with comorbidities.
Keywords: Congestive heart failure, comorbidity, echocardiography, imaging, MRI, review.
Rights & PermissionsPrintExport